 |
Julphar enters oncology market in deal with BiocadJulphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced its entry into the oncology market through a licence and supply agreement with Russia’s leading biotechnology company, Biocad. More… |
 |
Julphar to supply disposable insulin pens in UAEJulphar, a top pharmaceutical manufacturer in the Middle East and Africa, has signed an agreement with leading global medical technology company, BD (Becton, Dickinson and Company), to supply disposable insulin pens in the UAE. BD More… |
|
Julphar to supply disposable insulin pens in UAEJulphar, a top pharmaceutical manufacturer in the Middle East and Africa, has signed an agreement with leading global medical technology company, BD (Becton, Dickinson and Company), to supply disposable insulin pens in the UAE. BD More… |
 |
Julphar wins ‘Best Emerging GCC Pharma firm’ awardJulphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), has won the Frost & Sullivan 2018 Award for the Best Emerging GCC Pharma Company. The awards programme, now in its fourth year, is b More… |
 |
Julphar reports $5m net profit in Q1UAE-based Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), has reported first quarter 2018 sales of Dh264.0 million ($71.87 million) and a net profit of Dh18.4 million ($5.0 million). T More… |
 |
Julphar-MSD partnership wins top ASAP awardJulphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), has won the Association of Strategic Alliance Professionals (ASAP) award for 2018 along with its alliance partner, MSD. MSD (known More… |
 |
Julphar named top pharma company in UAEJulphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong double digit sales growth versus 2017. Julpha More… |
|
Julphar named top pharma company in UAEJulphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong double digit sales growth versus 2017. Julpha More… |
 |
Julphar records sales of $353.9m in 2017UAE-based Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), recorded sales of Dh1.3 billion ($353.9 million) for the year ending December 31, 2017, despite the challenging and rapidly changing market e More… |
 |
Julphar receives top recognition from Saudi food authorityUAE-based Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has been awarded Current Good Manufacturing Practice (cGMP) approval by the Saudi Food and Drug Authority (SFDA). Julphar Saudi Arab More… |
